Cellular Health Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Cellular Health Screening market is segmented by type (Single Test Panels, and Multi-Test Panels), By Sample Type (Blood Samples, Urine Samples, and Other Samples), and Geography

Cellular Health Screening Market Snapshot

Cellular Health Screening Market CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: <8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of the market is attributed to rising applications of cellular health screening in personalized medicine, and increasing government focus towards preventive healthcare. The potential applications of cellular health screening in personalized medicine have provided significant growth opportunities to market players in this field. According to a research study conducted by the University of Utah GSLC, researchers were able to achieve blocking of telomerase activity in prostate and breast cancer cells that were cultured in the laboratory resulting in the death of tumor cells. Therefore, these researches conducted by various institutes lead to a rise in the use of telomere test kits in cellular health screening and other application areas, which is expected to drive the cellular health screening market in the forecast period.

However, the risk associated with the transport of samples is expected to restrain the growth of the global market in the forecast period.

Scope of the Report

As per the scope of the report, cellular health screening determines the cellular toxicity, fat mass, cellular health and function, intracellular and extracellular fluid levels, and the quantity and quality of active cell mass (muscle mass).

By Type
Single Test Panels
Telomere Tests
Oxidative Stress Tests
Inflammation Tests
Heavy Metals Tests
Multi-Test Panels
By Sample Type
Blood Samples
Urine Samples
Other Samples
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Single Test Panels Segment is Expected to Dominate the Market over the Forecasted Period

Based on type, the Cellular Health Screening market is segmented into single test panels and multi-test panels. single test panels segment is expected to dominate the market and accounts for a larger share of the cellular health screening market as these panels are used to get more accurate information and help in performing cellular health screening test to measure the length of the telomere, thereby preventing diseases. Furthermore, with the rising geriatric population, the preference of telomere tests is expected to rise as it facilitates individuals to check their cellular age and thereby take preventive measures, which contributes to the high growth of the cellular health screening market.

Cellular Health Screening Market

North America leads the Cellular Health Screening Market

North America leads the Cellular Health Screening Market owing to high patient pool and rising disease prevalence, followed by Europe. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States. Furthermore, the growing cases of chronic diseases are  expected to drive R&D of the companies and thus, healthcare providers are shifting towards better mode of disease screening. On the other hand, the high growth in the Asia Pacific is due to the rise in government initiatives for preventive healthcare. For instance, in 2018, the government of Australia invested USD 10 million in research with an aim to prevent diseases and promote better health choices. These initiatives will likely propel the growth of cellular health screening market.

Cellular Health Screening Market

Competitive Landscape

Many of the global players are into the Cellular Health Screening Market. For instance - Bio-Reference Laboratories, Inc., Genova Diagnostics, Immundiagnostik AG, Quest Diagnostics, SpectraCell Laboratories, Inc., Telomere Diagnostics Inc. etc. are providing these products across the globe.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Applications of Cellular Health Screening in Personalized Medicine

      2. 4.2.2 Increasing Government Focus Towards Preventive Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Risk Associated With the Transport of Samples

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Single Test Panels

        1. 5.1.1.1 Telomere Tests

        2. 5.1.1.2 Oxidative Stress Tests

        3. 5.1.1.3 Inflammation Tests

        4. 5.1.1.4 Heavy Metals Tests

      2. 5.1.2 Multi-Test Panels

    2. 5.2 By Sample Type

      1. 5.2.1 Blood Samples

      2. 5.2.2 Urine Samples

      3. 5.2.3 Other Samples

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bio-Reference Laboratories, Inc. (OPKO Health)

      2. 6.1.2 Genova Diagnostics

      3. 6.1.3 Immundiagnostik AG

      4. 6.1.4 Laboratory Corporation of America Holdings

      5. 6.1.5 Quest Diagnostics

      6. 6.1.6 Segterra, Inc.

      7. 6.1.7 SpectraCell Laboratories, Inc.

      8. 6.1.8 Telomere Diagnostics Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cellular Health Screening Market market is studied from 2018 - 2026.

The Cellular Health Screening Market is growing at a CAGR of <8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bio-Reference Laboratories, Inc., Genova Diagnostics, Immundiagnostik AG, Quest Diagnostics, SpectraCell Laboratories, Inc. are the major companies operating in Cellular Health Screening Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!